XML 30 R19.htm IDEA: XBRL DOCUMENT v3.26.1
Segment Data
 6 Months Ended
Jun. 30, 2026
Segment Reporting [Abstract]  
Segment Data Segment Data
The Company consists of a single operating and reportable segment and uses consolidated net income as its measure of segment profit and loss. The chief operating decision maker of the Company is the Chief Executive Officer (CEO). The CEO reviews consolidated operating results to make decisions about how to allocate resources to the segment and assess its performance as a whole. The Company has identified the following significant segment expenses (SSEs) due to their relevance to the overall consolidated operating results (in thousands):
Three Months Ended June 30,Six Months Ended June 30,
2026202520262025
Net sales from external customers$173,964 $151,176 $328,166 $299,324 
Significant segment expenses:
Materials68,351 62,510 127,419 123,876 
Salaries and Benefits53,419 42,911 103,791 86,873 
Depreciation and amortization4,965 4,719 9,864 9,353 
Interest expense, net1,711 2,671 3,448 5,480 
Other segment items (a)19,090 16,739 35,608 31,835 
Income before income tax provision26,428 21,626 48,036 41,907 
Income tax provision5,577 4,446 9,690 7,543 
Segment net income$20,851 $17,180 $38,346 $34,364 
Segment total assets (b)$681,909 
(a)Other segment items include (production overhead, stock compensation, professional fees, and other selling, general, and administrative expenses ("SG&A") expenses)
(b)See Condensed Consolidated Balance Sheet for details
Information about Geographic Areas
Net sales shipped to customers outside of the United States comprised approximately 16.8%, and 17.6% of the Company’s consolidated net sales for the three and six months ended June 30, 2026, respectively. Net sales shipped to customers outside of the United States comprised approximately 17.0% and 17.1% of the Company’s consolidated net sales for the three and six months ended June 30, 2025, respectively. Approximately 34.7% of all long-lived assets are located outside of the United States as of June 30, 2026 .
Information about Major Customers
Net sales to two customers comprised approximately 26.2% and 21.0% respectively, of the Company’s consolidated net sales for the three months ended June 30, 2026. Net sales to two customers comprised approximately 25.5% and 21.5% respectively, of the Company’s consolidated net sales for the six months ended June 30, 2026. Net sales to two customers comprised approximately 20.5% and 27.4% respectively, of the Company’s consolidated net sales for the three months ended June 30, 2025. Net sales to two customers comprised approximately 22.2% and 24.4% respectively, of the Company’s consolidated net sales for the six months ended June 30, 2025.
As of June 30, 2026, two customers represented approximately 27.9% and 13.0% respectively of the Company's gross accounts receivable. As of December 31, 2025, one customer represented approximately 32.1% of the Company's gross accounts receivable.
The Company’s products are primarily sold to customers within the Medical and Non-medical markets. Sales by market for the three and six months ended June 30, 2026 and 2025 are as follows (in thousands):
Three Months Ended June 30,Six Months Ended June 30,
2026202520262025
MarketNet Sales%Net Sales%Net Sales%Net Sales%
Medical$162,190 93.2%$139,335 92.2%$305,568 93.1%$274,749 91.8%
Non-medical11,774 6.8%11,841 7.8%22,598 6.9%24,575 8.2%
Net Sales$173,964 100.0%$151,176 100.0%$328,166 100.0%$299,324 100.0%